{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:04:01Z","timestamp":1787652241695,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T00:00:00Z","timestamp":1385683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T00:00:00Z","timestamp":1385683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/ijo.2013.225","type":"journal-article","created":{"date-parts":[[2013,11,29]],"date-time":"2013-11-29T08:32:38Z","timestamp":1385713958000},"page":"1097-1103","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["A comparative study of five centrally acting drugs on the pharmacological treatment of obesity"],"prefix":"10.1038","volume":"38","author":[{"given":"H","family":"Suplicy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C L","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M C","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"do Desterro de Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D R","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Radominski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,29]]},"reference":[{"key":"BFijo2013225_CR1","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1210\/jc.2004-0535","volume":"89","author":"GA Bray","year":"2004","unstructured":"Bray GA . Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583\u20132589.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013225_CR2","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","volume":"363","author":"de Berrington","year":"2010","unstructured":"Berrington de, Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211\u20132219.","journal-title":"N Engl J Med"},{"key":"BFijo2013225_CR3","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.2337\/dc11-0874","volume":"34","author":"JL Unick","year":"2011","unstructured":"Unick JL, Beavers D, Jakicic JM, Kitabchi AE, Knowler WC, Wadden TA et al. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care 2011; 34: 2152\u20132157.","journal-title":"Diabetes Care"},{"key":"BFijo2013225_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/joim.12012","volume":"273","author":"L Sj\u00f6str\u00f6m","year":"2013","unstructured":"Sj\u00f6str\u00f6m L . Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med 2013; 273: 219\u2013234.","journal-title":"J Intern Med"},{"key":"BFijo2013225_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1463-1326.2011.01554.x","volume":"14","author":"ID Caterson","year":"2012","unstructured":"Caterson ID, Finer N, Coutinho W, Van Gaal LF, Maggioni AP, Torp-Pedersen C et al. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab 2012; 14: 523\u2013530.","journal-title":"Diabetes Obes Metab"},{"key":"BFijo2013225_CR6","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","volume":"365","author":"P Sumithran","year":"2011","unstructured":"Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med 2011; 365: 1597\u20131604.","journal-title":"N Engl J Med"},{"key":"BFijo2013225_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/sj.ijo.0801889","volume":"26","author":"CK Haddock","year":"2002","unstructured":"Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M . Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 2002; 26: 262\u2013273.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFijo2013225_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.7326\/0003-4819-142-7-200504050-00012","volume":"142","author":"Z Li","year":"2005","unstructured":"Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005; 142: 532\u2013546.","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"BFijo2013225_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1467-789X.2007.00333.x","volume":"8","author":"JP Wilding","year":"2007","unstructured":"Wilding JP . Treatment strategies for obesity. Obes Rev 2007; 8 (Suppl 1): 137\u2013144.","journal-title":"Obes Rev"},{"issue":"11 Suppl 1","key":"BFijo2013225_CR10","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1210\/jc.2008-1294","volume":"93","author":"GA Bray","year":"2008","unstructured":"Bray GA . Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab 2008; 93 (11 Suppl 1): S81\u2013S88.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2013225_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7326\/0003-4819-143-5-200509060-00013","volume":"143","author":"E Colman","year":"2005","unstructured":"Colman E . Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann Intern Med 2005; 143: 380\u2013385.","journal-title":"Ann Intern Med"},{"key":"BFijo2013225_CR12","first-page":"3","volume":"26","author":"F Borsini","year":"1979","unstructured":"Borsini F, Bendotti C, Carli M, Poggesi E, Samanin R . The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine. Res Commun Chem Pathol Pharmacol 1979; 26: 3\u201311.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BFijo2013225_CR13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bbr.2010.03.023","volume":"211","author":"A Santamar\u00eda","year":"2010","unstructured":"Santamar\u00eda A, Arias HR . Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats. Behav Brain Res 2010; 211: 132\u2013139.","journal-title":"Behav Brain Res"},{"key":"BFijo2013225_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ijo.2009.124","volume":"33","author":"C Cercato","year":"2009","unstructured":"Cercato C, Roizenblatt VA, Lean\u00e7a CC, Segal A, Lopes Filho AP et al. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects. Int J Obes (Lond) 2009; 33: 857\u2013865.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2013225_CR15","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/jat\/23.3.187","volume":"23","author":"JT Cody","year":"1999","unstructured":"Cody JT, Valtier S, Stillman S . Amphetamine and fenproporex levels following multidose administration of fenproporex. J Anal Toxicol 1999; 23: 187\u2013194.","journal-title":"J Anal Toxicol"},{"key":"BFijo2013225_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1046\/j.1467-789X.2003.00083.x","volume":"4","author":"A Halpern","year":"2003","unstructured":"Halpern A, Mancini MC . Treatment of obesity: an update on anti-obesity medications. Obes Rev 2003; 4: 25\u201342.","journal-title":"Obes Rev"},{"issue":"Suppl 4","key":"BFijo2013225_CR17","doi-asserted-by":"publisher","first-page":"549S","DOI":"10.1002\/j.1550-8528.1995.tb00226.x","volume":"3","author":"S Inoue","year":"1995","unstructured":"Inoue S . Clinical studies with mazindol. Obes Res 1995; 3 (Suppl 4): 549S\u2013552S.","journal-title":"Obes Res"},{"key":"BFijo2013225_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/0269881107083837","volume":"22","author":"PJ Wellman","year":"2008","unstructured":"Wellman PJ . Systemic mazindol reduces food intake in rats via suppression of meal size and meal number. J Psychopharmacol 2008; 22: 532\u2013535.","journal-title":"J Psychopharmacol"},{"key":"BFijo2013225_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/157015912799362788","volume":"10","author":"JR Ara\u00fajo","year":"2012","unstructured":"Ara\u00fajo JR, Martel F . Sibutramine effects on central mechanisms regulating energy homeostasis. Curr Neuropharmacol 2012; 10: 49\u201352.","journal-title":"Curr Neuropharmacol"},{"key":"BFijo2013225_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM et al. Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BFijo2013225_CR21","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/15622975.2011.602720","volume":"12","author":"M Aigner","year":"2011","unstructured":"Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force on Eating Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 2011; 12: 400\u2013443.","journal-title":"World J Biol Psychiatry"},{"key":"BFijo2013225_CR22","first-page":"129","volume":"18","author":"DJ Goldstein","year":"1994","unstructured":"Goldstein DJ, Rampey AH Jr, Enas GG, Potvin JH, Fludzinski LA, Levine LR . Fluoxetine: a randomized clinical trial in the treatment of obesity. Int J Obes Relat Metab Disord 1994; 18: 129\u2013135.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFijo2013225_CR23","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","volume":"71","author":"A Serretti","year":"2010","unstructured":"Serretti A, Mandelli L . Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 2010; 71: 1259\u20131272.","journal-title":"J Clin Psychiatry"},{"key":"BFijo2013225_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905\u2013917.","journal-title":"N Engl J Med"},{"key":"BFijo2013225_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Ball R, Ranieri W . Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996; 67: 588\u2013597.","journal-title":"J Pers Assess"},{"key":"BFijo2013225_CR26","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006X.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56: 893\u2013897.","journal-title":"J Consult Clin Psychol"},{"key":"BFijo2013225_CR27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1590\/S1516-44462001000400008","volume":"23","author":"S Freitas","year":"2001","unstructured":"Freitas S, Lopes CS, Coutinho W, Appolinario JC . Translation and adaptation into Portuguese of the Binge-Eating Scale. Rev Bras Psiquiatr 2001; 23: 215\u2013220.","journal-title":"Rev Bras Psiquiatr"},{"key":"BFijo2013225_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473\u2013483.","journal-title":"Med Care"},{"key":"BFijo2013225_CR29","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","volume":"41","author":"WHOQOL Group","year":"1995","unstructured":"WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403\u20131409.","journal-title":"Soc Sci Med"},{"key":"BFijo2013225_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/j.1550-8528.1995.tb00120.x","volume":"3","author":"RL Kolotkin","year":"1995","unstructured":"Kolotkin RL, Head S, Hamilton M, Tse CK . Assessing impact of weight on quality of life. Obes Res 1995; 3: 49\u201356.","journal-title":"Obes Res"},{"key":"BFijo2013225_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"BFijo2013225_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0197-2456(00)00046-5","volume":"21","author":"JM Lachin","year":"2000","unstructured":"Lachin JM . Statistical considerations in the intent-to-treat principle. Control Clin Trials 2000; 21: 167\u2013189.","journal-title":"Control Clin Trials"},{"key":"BFijo2013225_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1590\/S0004-27302009000200018","volume":"53","author":"W Coutinho","year":"2009","unstructured":"Coutinho W . The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Arq Bras Endocrinol Metabol 2009; 53: 262\u2013270.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"BFijo2013225_CR34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","volume":"377","author":"KM Gadde","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 1341\u20131352.","journal-title":"Lancet"},{"issue":"Suppl 4","key":"BFijo2013225_CR35","first-page":"S67","volume":"16","author":"DS Gray","year":"1992","unstructured":"Gray DS, Fujioka K, Devine W, Bray GA . A randomized double-blind clinical trial of fluoxetine in obese diabetics. Int J Obes Relat Metab Disord 1992; 16 (Suppl 4): S67\u2013S72.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 1","key":"BFijo2013225_CR36","doi-asserted-by":"publisher","first-page":"181S","DOI":"10.1093\/ajcn\/55.1.181s","volume":"55","author":"SD Wise","year":"1992","unstructured":"Wise SD . Clinical studies with fluoxetine in obesity. Am J Clin Nutr 1992; 55 (Suppl 1): 181S\u2013184S.","journal-title":"Am J Clin Nutr"},{"key":"BFijo2013225_CR37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa0909809","volume":"363","author":"SR Smith","year":"2010","unstructured":"Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245\u2013256.","journal-title":"N Engl J Med"},{"key":"BFijo2013225_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","volume":"376","author":"FL Greenway","year":"2010","unstructured":"Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2010; 376: 595\u2013605.","journal-title":"Lancet"},{"key":"BFijo2013225_CR39","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/oby.2003.152","volume":"11","author":"SH Kim","year":"2003","unstructured":"Kim SH, Lee YM, Jee SH, Nam CM . Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials. Obes Res 2003; 11: 1116\u20131123.","journal-title":"Obes Res"},{"key":"BFijo2013225_CR40","doi-asserted-by":"publisher","first-page":"179674","DOI":"10.1155\/2011\/179674","volume":"2011","author":"LL Ioannides-Demos","year":"2011","unstructured":"Ioannides-Demos LL, Piccenna L, McNeil JJ . Pharmacotherapies for obesity: past, current, and future therapies. J Obes 2011; 2011: 179674.","journal-title":"J Obes"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijo2013225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2013225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2013225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T18:20:49Z","timestamp":1647368449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2013225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,29]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFijo2013225"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2013.225","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,29]]},"assertion":[{"value":"4 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}